The safety of chemotherapy for breast cancer patients with hepatitis c virus infection

Journal of Cancer

Volumn 4, Issue 6, 2013, Pages 519-523

  Miura, Yuji ^a   Theriault, Richard L ^b   Naito, Yoichi ^a   Suyama, Koichi ^a   Shimomura, Akihiko ^a   Iwatani, Tsuguo ^a   Miura, Daishu ^a   Kawabata, Hidetaka ^a   Kumada, Hiromitsu ^a   Takano, Toshimi ^a  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy.; Child Pugh criteria; Febrile neutropenia; HCV; HCV RNA; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEUTROPHIL COUNT; PATIENT SAFETY; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTE COUNT; VIRUS LOAD;

EID: 84883046338     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.6231     Document Type: Article

References (16)

1. Tanaka J, Kumagai J, Katayama K, et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology. 2004;47:32-40.
2. Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Japanese journal of clinical oncology. 2012;42:139-47.
3. Artz AS, Somerfield MR, Feld JJ, et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28:3199-202.
4. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-2.
5. Hsieh CY, Huang HH, Lin CY, et al. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26:2584-6.
6. Coppola N, Pisaturo M, Guastafierro S, et al. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy. Dig Liver Dis. 2012;44:49-54.
7. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1998;11:155-68.
8. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25:118-45.
9. Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:2932-47.
10. Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. Journal of clinicaloncology : official journal of the American Society of Clinical Oncology. 2011;29:4189-98.
11. Melisko ME, Fox R, Venook A. Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clin Oncol (R Coll Radiol). 2004;16:204-5.
12. Morrow PK, Tarrand JJ, Taylor SH, et al. Effects of chronic hepatitis C infection on the treatment of breast cancer patients. Ann Oncol. 2010;21:1233-6.
13. Nooka A, Shenoy PJ, Sinha R, et al. Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature. Clin Lymphoma Myeloma Leuk. 2011;11:379-84.
14. Charlton M. Hepatitis C infection in liver transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2001;1:197-203.
15. Muss HB, Berry DA, Cirrincione C, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25:3699-704.
16. Crivellari D, Bonetti M, Castiglione-Gertsch M, et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000;18:1412-22.